Thermo Fisher Scientific (TMO)
$501.99
3.70 (0.74%)
TMO Stock Quote Delayed 30 Minutes
Thermo Fisher is More Than a Big Covid Winner
Covid-19 brought $2 billion in revenue to Thermo Fisher during the third quarter, and the company will put it to work for the next decade of biotech drug discovery.
11 Best Stocks to Buy for 2023
INSIDE: Investing legend Louis Navellier reveals his Top 11 Stocks for 2023 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
197.49B
PE Ratio
34.31
EPS
14.63
Volume (Avg. Vol.)
351,281
Day's Range
$500.48 - $507.40
52-Week Range
$475.77 - $609.85
Dividend & Yield
$0.88 (0.18%)
TMO Stock Predictions, Articles, and Thermo Fisher Scientific News
3 Big Stock Charts for Friday: JD.com, Charter, and Thermo Fisher
Friday's big stock charts feature three large-cap names that have found a bottom — and which could keep rallying, particularly with outside help.
Stock Market Today: Emergency Fed Response; Buy AMD?
We saw equities fall in the stock market today, despite the Federal Reserve stepping up with an emergency 50-basis-points rate cut.
Thermo Fisher (TMO) to buy Brammer Bio for $1.7B
Thermo Fisher (TMO) will shell out $1.7 billion to buy Brammer Bio in order to continue the company's progress in the gene therapy field.
3 Big Stock Charts for Friday: Thermo Fisher Scientific, Intuit and Intercontinental Exchange
Stock charts of Thermo Fisher Scientific, Intuit Intercontinental Exchange have all earned a closer inspection here.
7 Stocks on a Long-Term Uptrend
Looking for some stocks to buy that you don't have to babysit? These names are in a bullish groove that looks secure enough.
Thermo Fisher Scientific (TMO) a Buy on Superior Sales Growth
Thermo Fisher Scientific Inc (NYSE:TMO) is ranked as a Buy using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. TMO has maintained this ranking for 2 months.
Thermo Fisher Scientific (TMO) Ranking Raised to Buy on Strong Earnings Growth
Thermo Fisher Scientific Inc (NYSE:TMO) is ranked as a Buy using the system of Louis Navellier for investing and his Portfolio Grader stock evaluator. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.
Thermo Fisher Scientific (TMO) Upgraded to Buy from a Hold
The current recommendation of Buy for Thermo Fisher Scientific Inc (NYSE:TMO) is derived using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing system. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.
Sagging Quant Score Downgrades Thermo Fisher Scientific (TMO) to Hold
Thermo Fisher Scientific Inc (NYSE:TMO) ranks in the top 10% of its industry group, Life Sciences Tools & Services, and in the top 10% of its sector group, Health Care, with a market value of $74.7 billion. From an investment attractiveness prospective, TMO is ranked in the top half of the sector with a ranking of 311 among the 782 companies in the sector; the ranking for TMO by Portfolio Grader places it 20 among the 33 companies in this industry group, giving it a lower than average position and number 1,957 in the 5000 company Portfolio Grader company universe.
Earnings Visibility Keep Thermo Fisher Scientific (TMO) a Buy
Thermo Fisher Scientific Inc (NYSE:TMO) is one of the 785 companies in the GICS Health Care sector, and a constituent of the 33 company Life Sciences Tools & Services GICS industry group within this sector. The market value of TMO is $77.7 billion which falls in the top 10% of its industry group. The ranking for TMO by Portfolio Grader places it 17 among the 33 companies in this industry group, giving it a below-average spot; in the top half of the sector with a ranking of 234 among the 785 companies in the sector, and number 1,518 in the nearly 5,000 company Portfolio Grader universe.
Quant Score Makes Thermo Fisher Scientific (TMO) a Buy
Portfolio Grader currently ranks Thermo Fisher Scientific Inc (NYSE:TMO) a Buy. The methodology for investing incorporated in this analytical tool developed by Louis Navellier researches and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. TMO has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy.
